Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation
7,000 enrolled
ELEPHAS-04
Recruiting
324 enrolled
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
Recruiting
130 enrolled
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
Active not recruiting
72 enrolled
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
Recruiting
500 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
ARIS
Completed
350 enrolled
START
Terminated
10 enrolled
LOLA-PROJECT
Enrolling by invitation
500 enrolled
Integrin αvβ6-targeted PET in Malignant Tumors
Recruiting
200 enrolled
CA209-1529
Not yet recruiting
500 enrolled
PROFIL-1
Not yet recruiting
120 enrolled
FINN
Active not recruiting
825 enrolled
Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment
Completed
22,517 enrolled
The Impact of Radiotherapy on Oligometastatic Cancer
Recruiting
2,000 enrolled
LUTON
Terminated
6 enrolled
CER
Recruiting
15,000 enrolled
LORLAPULM
Completed
118 enrolled
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
Terminated
22 enrolled
Impact of ctDNA in Cancer Early Detection and STAS Evaluation in Patients With GGOs
Unknown
80 enrolled
SPACE2
Unknown
150 enrolled
NEPTUN
Completed
408 enrolled
CHAPLIN
Completed
154 enrolled
Whole-Exome Sequencing (WES) of Cancer Patients
Completed
244 enrolled
PIONEER
Unknown
1,000 enrolled
I-SABR2_PDA
Unknown
126 enrolled
PROXie
Completed
253 enrolled
REVEAL
Completed
141 enrolled
SPECIALK
Unknown
500 enrolled
Establishment of a PDT Patient Registry
Terminated
22 enrolled
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Completed
3,571 enrolled
CANPOS
Unknown
250 enrolled
LCLC
Recruiting
1,000 enrolled
Validation of a Kinetic Model of Erlotinib
Unknown
50 enrolled
Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer
Completed
228 enrolled
Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer
Withdrawn
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
Withdrawn
LYMPHOS1
Completed
179 enrolled
PFS
Completed
50 enrolled
Characterization of Brain Metastases
Completed
26 enrolled
Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors
Unknown
408 enrolled
Study of Episodic Breathlessness in Patients With Lung Cancer or Other Advanced Disease
Completed
50 enrolled
FRAME
Completed
1,610 enrolled
Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer
Unknown
120 enrolled
Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.
Withdrawn
Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
Completed
24 enrolled
Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia
Unknown
270 enrolled
Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)
Completed
90 enrolled
Molecular Mechanism of Trophinin in Cancer Invasion and Metastasis
Completed
150 enrolled